Starling Oncology, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Starling Oncology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $220.00K.
- Starling Oncology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $151.00K.
- Starling Oncology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $151.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $220.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $151.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $151.00K 10-Q · filed 2025-11-13 |